Tumor hypoxia renders treatments
ineffective that are directly
(e.g., radiotherapy and photodynamic therapy) or indirectly (e.g.,
chemotherapy) dependent on tumor oxygenation. This study introduces
a ruthenium compound as a light-responsive anticancer agent that is
water-soluble, has minimal dark cytotoxicity, is active at concentrations
as low as 170 pM in ∼18.5% O2 normoxia and near
10 nM in 1% O2 hypoxia, and exhibits phototherapeutic indices
as large as >500,000 in normoxia and >5,800 in 1% O2 hypoxia
using broadband visible and monochromatic blue light treatments. These
are the largest values reported to date for any compound class. We
highlight the response in four different cell lines to improve rigor
and reproducibility in the identification of promising clinical candidates.
Synthesis and encapsulation properties of two new water-soluble resorcinol-capped organic cavitands (tetra acid and octa acid; RTA and ROA) are reported in this Letter. Organic guest molecules template the formation of capsular assembly of the above cavitands in water. Depending upon the guest, either 1:2 (guest to host) or 2:2 capsular assemblies were formed. The excited state properties of guests such as anthracene, camphorthione, and 4,4'-dimethyl benzil were distinctly different within a capsular assembly from those when they were free in a solution. Importantly, the host-guest complexes of the above two hosts (RTA and ROA) as well as octa acid (OA) could be transferred to a silica surface. The excited state behavior of host-guest assemblies on silica surface resembled that in solution. The high cage effect in the decarbonylation products and high yield of rearrangement product obtained upon photolysis of 1-phenyl-3-tolyl-2-propanone included within RTA, ROA, and OA both in solution and on silica surface supported the conclusion that capsular assemblies of these hosts are stable on silica surface.
In an earlier study of π‐expansive ruthenium complexes for photodynamic and photochemo‐therapies, it was shown that a pair of structural isomers differing only in the connection point of a naphthalene residue exhibited vastly different biological activity. These isomers are further explored in this paper through the activity of their functionalized derivatives. In normoxia, the inactive 2‐NIP isomer (5) can be made as photocytotoxic as the active 1‐NIP isomer (1) by functionalizing with methyl or methoxy groups, while methoxy variants of the 1‐NIP isomer became inactive. In all cases, the singlet oxygen sensitization quantum yield was below 1%. Hypoxic photocytotoxicity was attenuated, with only three of the series showing any activity, notwithstanding the photodissociative ligands. The results here are consistent with the earlier findings in that seemingly minor structural modifications on the non‐strained ligand can dramatically modulate the normoxic and hypoxic activity of these strained compounds and that these changes appear to exert a greater influence on photocytotoxicity than singlet oxygen sensitization or rates of photosubstitution in cell‐free conditions would suggest.
The excited state behavior of two flavone derivatives 3-hydroxyflavone and 4'-N,N-diethylaminoflavonol in a confined medium indicates that supramolecular effects could alter the nature of the fluorescence emission. Within the octa acid host the neutral unionized species of these two dyes are present showing large Stokes shifted emission due to intramolecular proton transfer, a pattern different from that in aqueous medium.
The photophysics of three benzothiazole derivatives that exhibit excited state intramolecular proton transfer (ESIPT) were investigated in a confined medium afforded by the water soluble supramolecular host octaacid (OA).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.